COM:AMOLYTPHARMA
Amolyt Pharma
- Privately Held
locale
Francemarket
PRIVATEindustry
Healthcare & Health Serviceswebsite
amolytpharma.comcrunchbase
amolyt-pharmalinkedin
amolytpharmafounding date
Jan 01, 2015
Amolyt Pharma is a biopharmaceutical company focused on developing treatments for hypoparathyroidism, a rare endocrine disorder. The company is developing eneboparatide, a novel parathyroid hormone receptor 1 (PTHR1) agonist, which has demonstrated promising results in clinical trials.